Biomedical Applications of Nanoparticles
Nanomaterials hold immense promise for significantly improving existing diagnosis, therapy and designing novel approaches to treat a variety of human ailments. While some of the applications of nanotechnology have been translated into clinical settings, many more potential uses of nanomedicines have been demonstrated in experimental systems. Since a variety of materials can be nanosized, the scope of nanomedicine is also large and may even become larger. At the same time, the impact of nanomaterials on cellular and animal models will need to be carefully evaluated under both acute and chronic exposures at toxicological and pharmacological doses. It is extremely important to evaluate the basic issues such as the fate of nanomaterials in biological systems, and how the cells and tissues react to the exposure of nanomaterials in developing nanomedicines. This chapter will cover some of these promises and future directions.
KeywordsIron Oxide Nanoparticles Polymeric Micelle Iron Oxide Particle Gold Nanoshells Nanosized Material
I thank Dr. Linda Knight, Professor of Diagnostic Imaging at Temple University School of Medicine, for critical reading and helpful suggestions with the manuscript.
- 11.Freitas RA Jr (1999) Nanomedicine, volume I: basic capabilities, 1st edn. Landes Bioscience, Georgetown, TX.Google Scholar
- 12.Freitas RA Jr (2003) Nanomedicine, voulme iia: biocompatibility, 1st edn. Landes Bioscience, Georgetown, TX.Google Scholar
- 15.Dresselhaus MS, Dresselhaus G, Eklund, PC (1996) Science of fullerenes and carbon nanotubes. Academic Press, San Diego, CA.Google Scholar
- 17.Tsao N, Kanakamma PP, Luh T-Y, Chou C-K, Lei H-Y (1999) Inhibition of escherichia coli-induced meningitis by carboxyfullerence. Antimicrob Agents Chemother 43:2273–2277.Google Scholar
- 31.Barone PW, Baik S, Heller DA, Strano MS (2005) Near-infrared optical sensors based on single-walled carbon nanotubes Nat Mater 4:86–92.Google Scholar
- 34.Courty S, Bouzigues C, Luccardini C, Ehrensperger M, Bonneau S, Dahan M, James I (2006) Tracking individual proteins in living cells using single quantum dot imaging. In “Methods in Enzymology”, Academic Press.Google Scholar
- 45.Sun R, Dittrich J, Le-Huu M, Mueller MM, Bedke J, Kartenbeck J, Lehmann WD, Krueger R, Bock M, Huss R, Seliger C, Grone HJ, Misselwitz B, Semmler W, Kiessling F (2005) Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison. Invest Radiol 40:504–513.CrossRefGoogle Scholar
- 46.Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 152:167–173.Google Scholar
- 53.O’Brien MER, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A, Catane R, Kieback DG, Tomczak P, Ackland SP, Orlandi F, Mellars L, Alland L, Tendler C (2004) Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYXTM/Doxil(R)) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol 15:440–449.CrossRefGoogle Scholar
- 56.Loo C, Lin A, Hirsch L, Lee MH, Barton J, Halas N, West J, Drezek R (2004) Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat 3:33–40.Google Scholar